BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30448999)

  • 1. Comorbid cancer and use of thrombolysis in acute pulmonary embolism.
    Weeda ER; Hakamiun KM; Leschorn HX; Tran E
    J Thromb Thrombolysis; 2019 Feb; 47(2):324-327. PubMed ID: 30448999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis.
    Weeda ER; Bohm N
    Int J Stroke; 2019 Jan; 14(1):48-52. PubMed ID: 29762085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saddle pulmonary embolism and in-hospital mortality in patients with cancer.
    Prentice A; Ruiz I; Weeda ER
    Int J Clin Oncol; 2019 Jun; 24(6):727-730. PubMed ID: 30746594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
    Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice patterns and complication rates of thrombolysis for pulmonary embolism.
    Bradford MA; Lindenauer PK; Walkey AJ
    J Thromb Thrombolysis; 2016 Oct; 42(3):313-21. PubMed ID: 26961258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Inferior Vena Cava Filter Placement on Short-Term Outcomes in Patients with Acute Pulmonary Embolism.
    Liang NL; Genovese EA; Avgerinos ED; Singh MJ; Makaroun MS; Chaer RA
    Ann Vasc Surg; 2017 Jul; 42():71-77. PubMed ID: 28341513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism.
    Riera-Mestre A; Jiménez D; Muriel A; Lobo JL; Moores L; Yusen RD; Casado I; Nauffal D; Oribe M; Monreal M;
    J Thromb Haemost; 2012 May; 10(5):751-9. PubMed ID: 22417297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims.
    Geller BJ; Adusumalli S; Pugliese SC; Khatana SAM; Nathan A; Weinberg I; Jaff MR; Kobayashi T; Mazurek JA; Khandhar S; Yang L; Groeneveld PW; Giri JS
    Vasc Med; 2020 Aug; 25(4):334-340. PubMed ID: 32338580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic thrombolysis increases hemorrhagic stroke risk without survival benefit compared with catheter-directed intervention for the treatment of acute pulmonary embolism.
    Liang NL; Avgerinos ED; Singh MJ; Makaroun MS; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):171-176.e1. PubMed ID: 28214483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of In-Hospital Outcomes and Readmission Rates in Acute Pulmonary Embolism Between Systemic and Catheter-Directed Thrombolysis (from the National Readmission Database).
    Arora S; Panaich SS; Ainani N; Kumar V; Patel NJ; Tripathi B; Shah P; Patel N; Lahewala S; Deshmukh A; Badheka A; Grines C
    Am J Cardiol; 2017 Nov; 120(9):1653-1661. PubMed ID: 28882336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy.
    Bozbay M; Uyarel H; Avsar S; Oz A; Keskin M; Murat A; Kaya A; Atas H; Cincin AA; Ugur M; Eren M
    Lung; 2016 Apr; 194(2):219-26. PubMed ID: 26896039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism.
    Avgerinos ED; Saadeddin Z; Abou Ali AN; Fish L; Toma C; Chaer M; Rivera-Lebron BN; Chaer RA
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):530-540. PubMed ID: 29909859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Thrombolysis for Acute Pulmonary Embolism in the United States: National Trends and Patient Characteristics from 2006 to 2011.
    Rush B; Wiskar K; Berger L; Griesdale DE
    J Emerg Med; 2017 May; 52(5):615-621. PubMed ID: 27899206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
    Chatterjee S; Weinberg I; Yeh RW; Chakraborty A; Sardar P; Weinberg MD; Kabrhel C; Barnes GD; Mukherjee D; Kumbhani D; Bashir R; Vaidya A; Smith A; Fuchs B; Groeneveld P; Giri J
    Thromb Haemost; 2017 Jan; 117(2):246-251. PubMed ID: 27882375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study.
    Lee JK; Chen WH; Lin YS; Chang CH; Chen TH
    Thromb Haemost; 2020 Aug; 120(8):1208-1216. PubMed ID: 32679597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter-based therapy for intermediate or high-risk pulmonary embolism is associated with lower in-hospital mortality in patients with cancer: Insights from the National Inpatient Sample.
    Leiva O; Yuriditsky E; Postelnicu R; Yang EH; Mukherjee V; Greco A; Horowitz J; Alviar C; Bangalore S
    Catheter Cardiovasc Interv; 2024 Feb; 103(2):348-358. PubMed ID: 37997287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Thrombolysis for Pulmonary Embolism: Who and How.
    Tapson VF; Friedman O
    Tech Vasc Interv Radiol; 2017 Sep; 20(3):162-174. PubMed ID: 29029710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of fibrinolytic therapy for patients with metastatic cancer and acute pulmonary embolism.
    Ogunbayo GO; Pecha R; Misumida N; Goodwin E; Ayoub K; Hillerson D; Elbadawi A; Abdel-Latif A; Elayi CS; Messerli AW; Smyth SS
    Pulm Pharmacol Ther; 2019 Jun; 56():104-107. PubMed ID: 30959093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and outcomes of lytic-based therapies for high-risk pulmonary embolism: A nationwide analysis.
    Abumoawad A; ElBallat A; Mkhaimer Y; Ghanem F; Obaed N; Bunte MC
    Vasc Med; 2024 Feb; 29(1):26-35. PubMed ID: 38084862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.
    Keller K; Hobohm L; Ebner M; Kresoja KP; Münzel T; Konstantinides SV; Lankeit M
    Eur Heart J; 2020 Jan; 41(4):522-529. PubMed ID: 31102407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.